hrp0082p1-d3-161 | Growth (2) | ESPE2014
, Woelfle Joachim
, Bang Peter
, Sicsic Aude
, Fiorentino Bruno
Background: The post-authorization registry, European Increlex® (Mecasermin (rDNA Origin) injection) growth forum database (EU-IGFD) was initiated in Dec 2008 to collect data on children with growth failure treated with Increlex®.Objective: To report 4-year safety and effectiveness data.Methods: Multicenter, open-label observational study, eCRF data collection.Results: As of 30...